Bildkälla: Stockfoto

Bactiguard: A step in the right direction - SEB

Q1 came in ahead of our estimates, with BD showing further signs of stabilising at pre-pandemic levels as well as high-single-digit organic sales growth in BIP products. Considering Bactiguard’s strengthened positioning via the expanded partnership with Zimmer Biomet, the new collaboration in the dental field, and an apparent pick-up in BIP product sales, we think Q1 was a clear step in the right direction.

Q1 came in ahead of our estimates, with BD showing further signs of stabilising at pre-pandemic levels as well as high-single-digit organic sales growth in BIP products. Considering Bactiguard’s strengthened positioning via the expanded partnership with Zimmer Biomet, the new collaboration in the dental field, and an apparent pick-up in BIP product sales, we think Q1 was a clear step in the right direction.
Börsvärldens nyhetsbrev
ANNONSER